Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Prof Fredrik Karpe and Dr Ioannis Spiliotis have been interviewed by BBC Oxford as part of World Diabetes Day 2017 (14 November).

© Geraldine Yebra
World Diabetes Day

Prof Fredrik Karpe discussed risk factors for type 2 diabetes and the need for volunteers to take part in research to help us find better ways of treating diabetes. It is becoming clear that there is no ‘one-stop’ treatment approach for the disease and by carrying out research in cohorts of volunteers through the Oxford Biobank, Prof Karpe and his team aim to better stratify patients for therapy. You can listen in to the interview here from 1:08:35.

Dr Ioannis Spiliotis highlighted the multi-disciplinary research taking place in OCDEM and raised awareness of the different forms of diabetes – and their causes. He delved into the complex interplay between genetics and lifestyle, and how they combine to cause diabetes. There was also discussion around gestational diabetes – the theme of this year’s World Diabetes Day. You can listen here from 1:08:00.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with


Similar stories

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

EASD-Robert Turner Clinical Research Training Course

This interactive and highly successful course returns to the face-to-face format in 3-7 April 2022 for its 18th year.

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.